Scrib inhibits the activation of extracellular signal-regulated kinase (ERK) pathways in various systems [3,19,54], and ERK and the mitogen-activated protein kinase (MAPK) signaling pathway are linked to neurodevelopmental disorders, including ASD [2,23,24,25]. Here, MAPK1 is linked to neurodevelopmental disorder.